Babak Azad - 08 Mar 2023 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Marketing Officer and SVP, Marketing & Communications
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad
Issuer symbol
GDRX
Transactions as of
08 Mar 2023
Net transactions value
-$44,490
Form type
4
Filing time
09 Mar 2023, 17:31:56 UTC
Previous filing
12 Dec 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +20,402 +111% 38,748 08 Mar 2023 Direct F1
transaction GDRX Class A Common Stock Tax liability $44,490 -8,089 -21% $5.50 30,659 08 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -20,402 -6.7% $0.000000 285,621 08 Mar 2023 Class A Common Stock 20,402 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximtely equal quarterly installments thereafter for 15 quarters.

Remarks:

Chief Marketing Officer and SVP, Marketing & Communications